Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAEmUPF9IZZ09c7PZNrGlebfDA6we8tcsZkGwXK_cuLws#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "farxiga dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies 14 farxiga is a sodium glucose cotransporter 2 sglt2 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 limitation of use 1 1 farxiga is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis" assertion.
- association object DOID_9352 assertion.
- association predicate treats assertion.
- DOID_9352 category Disease assertion.
- drugbank:DB06292 category Drug assertion.
- association subject drugbank:DB06292 assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.
- association relation TreatmentIndication assertion.